Daily Current Affairs / MSD launches India's first gender-neutral Human Papillomavirus Vaccine "Gardasil-9"
Category : Miscellaneous Published on: October 01 2021
· MSD Pharmaceuticals has launched India's first gender-neutral Human Papillomavirus (HPV) vaccine to reduce the HPV-related disease burden and cancer caused by the virus in Indian women, girls and boys.
· It is the only US Food and Drug Administration (USFDA) approved HPV vaccine that will help reduce HPV-related diseases and cancers in India.
· "Gardasil-9" is a three-dose nanovalent (9-valent) human papillomavirus or HPV vaccine that helps to reduce HPV-related diseases and cancers.
Important facts
About USFDA
· The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services.
· Founded: 30 June 1906
· Founders: Theodore Roosevelt, Harvey Washington Wiley
· Headquarters: Silver Spring, Maryland